Therefore, strategies to better mimic the heterogeneity of multi-specific T cell immunity caused by the natural infection would be required to leverage the vital role of both CD8+ and CD4+T cell responses in reducing the impact of COVID-19 and potentially provoking long-term immune responses (Dan et al., 2021). The gene discussed is CD8A; the disease is COVID-19.